Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on nanotechnology-driven delivery of small RNA mimics and inhibitors.
Translating today's discoveries in childhood cancer research into tomorrow's treatments.
Greehey Children’s Cancer Research Institute is only one of two institutes in the United States dedicated solely to pediatric cancer research. Its 19 laboratories focus their strengths in cancer genomics, DNA repair, RNA biology, and drug development on finding new and less toxic treatments for childhood cancers.
Top stories
Full SAPCS Agenda Announced
Click on Thumbnail Below for Full Details
News
Events
-
Greehey CCRI Seminar Series, Spring ’23: Lee Kraus, PhD – UT Southwestern
Presentation Title: “Role of Site-Specific ADP-Ribosylation in Cancer” -
San Antonio Pediatric Cancer Symposium (SAPCS)
The San Antonio Pediatric Cancer Symposium (SAPCS), hosted by the Greehey Children's Cancer Research Institute at UT Health San Antonio and in conjunction with the Mays Cancer Center, will bring together some of the most respected childhood cancer researchers from academia and industry; to discuss how advances in basic and translational sciences are impacting tomorrow's therapies and diagnoses. More info (including sessions, speakers, and registration) is coming soon!